biotx.ai

Great webinar on #predictivevalidity and #syntheticclinicaltrials, Nov 15, don't miss! lnkd.in/dkmqQ7sm #ai #drugdiscivery #eroomslaw

biotx.ai provides the platform to go all the way from biobank data to a treatment. Our team has developed a therapy for hospitalized #COVID19 patients in just a fraction of time compared to traditional drug development approaches. youtu.be/TlZEo_zv24c

ANNOUNCEMENT: We are proud to announce the results from the world's first synthetic clinical trial to prevent #thromboinflammation in severe #COVID19 patients have entered a Phase IIb clinical trial. We will cover this in our next webinar: bit.ly/3tJk8eK

@BrinkmannLab @_atanas_ @NeilFlochMD @hendrikstreeck @ianmackay23 @varghesetom4 @Laurie_Garrett @chrischirp @CatchTheBaby @VHackenbroch @LizSzabo @ashishkjha @JohnNosta @drsanjaygupta @friedberg @c_hebenstreit @jk_biotxai

#CausalInference reveals COVID-19 treatment option. We investigated the question of why some COVID-19 patients have a severe disease course and others do not. medrxiv.org/content/10.110…

@AstraZeneca Congratulation to the entire @AstraZeneca team!

The Discovery Centre (DISC) in Cambridge, UK, has been purposefully designed to be open, transparent and porous to encourage interaction between our researchers and the inspiring scientific, medical and R&D community around them. know.az/3FKXohV #WhatScienceCanDo

@JanssenGlobal Amazing work by you guys and glad we were able to contribute during the Janssen Quickfire challenge!

At Johnson & Johnson, we’re focused on innovations in early detection to transform the trajectory of #cancer. View here for perspectives about the importance of screening and improved diagnostic approaches as we aim to one day eliminate the disease: bit.ly/3qJTama

We're excited to host our 3rd @biotx_ai BEYOND webinar on Dec 8. This time it will be all about synthetic #clinicaltrials and causal inference in clinical risk #predictionmodels. Registrations are open, sign up today. bit.ly/3aMMqe9

Interaction-Based Feature Selection Algorithm Outperforms Polygenic Risk Score in Predicting Parkinson’s Disease Status #genomics #AI #Parkinsons #polygenic frontiersin.org/article/10.338…

We're looking forward to welcoming you all to our 2nd biotx BEYOND tomorrow. If you haven't signed up yet, there are still some seats left😉, don't miss it! bit.ly/3f4txWO #digitalhealth #clinicaltrials #ai #artificialntelligence #studiesandme

Join us at biotx #BEYOND on Sep 8 and learn, how you de-risk clinical trials with a better feature selection algorithm and being closer to patients by digitilizing all stages of a study. Sign up today! bit.ly/3f4txWO #digitalhealth #clinicaltrials #ai

For those who have missed our last biotx BEYOND webinar, watch our CEO Joern Klinger talking about how AI has spotted CDK6 inhibitors as a potential treatment of critically ill COVID-19 patients. lnkd.in/d6wYpAS